Archive for February, 2017

Review Article: Are the Infectious Roots of Alzheimer’s Buried Deep in the Past?

February 26, 2017

Dr. Lawrence Broxmeyer, MD

LINK-OUT TO REVIEW ARTICLE -51778-ipjpe-3-s2-2

Citation: Broxmeyer L. Are the Infectious Roots
of Alzheimer’s Buried Deep in the Past? J Mol
Path Epidemol. 2017, 3:2.

Received: January 13, 2017; Accepted: February 20, 2017; Published: February 22,
2017

© Under License of Creative Commons Attribution 3.0 License

Abstract

Recent literature shows a controversial new push to tie microorganisms to Alzheimer’s disease (AD). Study after study, in which scientists have injected human Alzheimer-diseased brain tissue into mice and other laboratory animals that later developed the disease have left little doubt that Alzheimer’s disease (AD) arises from an infectious process. By 2013 Mawanda and Wallace’s “Can Infections Cause Alzheimer’s Disease” struck down some of the commonly entertained pathogens for AD such as herpes simplex virus type 1, Chlamydia pneumoniae, and several types of spirochetes. Instead they pointed to two prime suspects for Alzheimer’s amyloid-beta deposition: “especially chronic infections like tuberculosis and leprosy.” To be sure, it was German neuropathologist Oskar Fischer of the Prague school of Neuropathology, Alzheimer’s great rival, who was the first to suggest that infection might be causative for Alzheimer’s. Fischer’s credentials: he was the co-discoverer of Alzheimer’s disease. His suspected germ was the Streptothrix, today classified as an Actinomycetes, a rare central nervous system pathogen which at the time was so constantly and consistently mistaken for tuberculosis that Choppen-Jones suggested that TB be called tuberculomycosis. And Just ten years before Oskar Fischer found Actinomycosis-like forms in Alzheimer’s cerebral plaque, Babèş and immunologist Levaditi reported in “On the Actinomycotic Shape of the Tuberculous Bacilli” that Fischer’s typical Actinomyces-like clusters [Drüsen] with clubs appeared in the tissue of rabbits inoculated with tubercle bacilli beneath the dura mater of their brains. Investigators who supported and subsequenly followed up on Fischer’s Alzheimer’s germ are also discussed.

Keywords: Alzheimer’s disease, Infectious Cause of Alzheimer’s Disease, Oskar Fischer, Alois Alzheimer, Neurodegenerative Disease, Neurotuberculosis

REFERENCES

  1. Itzhaki RF, Lathe R, Balin BJ, Ball MJ, Bearer EL, Braak H et al. Microbes and Alzheimer’s Disease. J Alzheimers Dis. 2016;51(4):979-84.
  2. Mawanda F, Wallace R. Can infections cause Alzheimer’s disease? Epidemiol Rev. 2013; 35:161-80.
  3. Itzhaki RF, Lin WR, Shang D, Wilcock GK, Faragher B, Jamieson GA. Herpes simplex virus type 1 in brain and risk of Alzheimer’s disease. Lancet. 1997 Jan 25;349(9047):241-44.
  4. Goldman JS, Hahn SE, Catania JW, LaRusse-Eckert S, Butson MB, Rumbaugh M et al. American College of Medical Genetics and the National Society of Genetic Counselors. Genetic counseling and testing for Alzheimer disease: joint practice guidelines of the American College of Medical Genetics and the National Society of Genetic Counselors. Genet Med. 2011; 13(6): 597-605.
  5. Mayeux R, Sanders AM, Shea S, Mirra S, Evans D, Roses AD, Hyman BT et al. Utility of the Apolipoprotein E Genotype in the Diagnosis of Alzheimer’s disease. NEJM. 1998; 338(8):506-511.
  6. Riviere GR, Riviere KH, Smith KS. Molecular and immunological evidence of oral Treponema in the human brain and their association with Alzheimer’s disease. Oral Microbiol Immunol. 2002;17(2):113–118.
  7. Goedert M. Oskar Fischer and the study of dementia. Brain. 2009 Apr; 132(4): 1102–1111.
  8. De Beer FC, Nel AE, Gie RP, Donald PR, Strachan AF. Serum amyloid A protein and C-reactive protein levels in pulmonary tuberculosis: relationship to amyloidosis. Thorax. 1984; 39(3):196–200.
  9. Looi LM, Jayalakshim P, Lim KJ, Rajagopalen K. An immunohistochemical and morphological study of amyloidosis complicating leprosy in Malaysian patients. Ann Acad Med Singapore. 1988; 17(4):573–578.
  10. Looi LM. The pattern of amyloidosis in Malaysia. Malays J Pathol. 1994; 16(1):11–13.
  11. Röcken C, Radun D, Glasbrenner B, Malfertheiner P, Roessner A. Generalized AA-amyloidosis in a 58-year-old Caucasian woman with an 18-month history of gastrointestinal tuberculosis. Virchows Arch. 1999; 434(1):95–100.
  12. Wangel AG, Wegelius O, Dyrting AE. A family study of leprosy: subcutaneous amyloid deposits and humoral immune responses. Int J Lepr Other Mycobact Dis. 1982; 50(1):47–55.
  13. Tank SJ, Chima RS, Shah V, et al. Renal amyloidosis following tuberculosis. Indian J Pediatr. 2000; 67(9):679–681.
  14. Urban BA, Fishman EK, Goldman SM,  Scott WW Jr, Jones B, Humphrey RL et al. CT evaluation of amyloidosis: spectrum of disease. Radiographics.1993; 13(6):1295–1308.
  15. Alzheimer A. “Uber Eigenartige Krankheitsfalle des Spateren Alters,” Zeit fur die Ges    Neur und Psych 1911; 4: 356–85.
  16. Barlow T. Tuberculous Meningitis in A System of Medicine by Many Writers, edited by Thomas Clifford Allbutt, New York:The Macmillan Company. 1899; 7:466–91.
  17. Ranke O. Beitrage zur Lehre von der Meningitis tuberculoa. Edited by Franz Nissl and Alois Alzheimer. Histologische und Histopathologische Arbeiten uber die Grosshirnrinde. Jena, Germany. Verlag Von Gustave Fischer. 1908; 252–347
  18. Alzheimer A, Forstl H, Levy R. An English translation of Alzheimer’s 1911 paper Uber Age), Hist of Psychia 1991. 2:71–101.
  19. Spielmeyer W. Alzheimer’s Lebenswenk. Zeit fur die Ges Neur und Psych. 1916; 22: 1–44.
  20. Dunn N, Mullee M, Perry VH, Holmes C. Association between Dementia and Infectious Disease: Evidence from a Case-Control Study. Alz Dis & Assoc Disord. April–June 2005. 19: 2: 91–4.
  21. Nee IE, Lipppa CF. Alzheimer’s Disease in Twenty-Two Twin Pairs—Thirteen-Year Follow-Up: Hormonal, Infectious, and Traumatic Factors.  Dement and Geriat Cognit Disord 1999; 10: 148–51.
  22. Alteri CJ, Xicahténcati-Cortes J, Hess S, Caballero-Olin G, Giron JA, Friedman RL. Mycobacterium Tuberculosis Produces Pili during Human Infection. Proc of the Nat Acad of Sci. 2007; 104:12:5145–50.
  23. Tukel C, Wilson RP, Nishimori JH, Pezeshki M, Chromy BA, Baumler AJ. Responses to Amyloids of Microbial and Host Origin Are Mediated through Toll-Like Receptor 2 Cell Host and Microbe. Cell Host Microb. July, 2009; 6: 45–53.
  24. Kidd M. Paired Helical Filaments in Electron Microscopy of Alzheimer’s Disease, Nature. 1963; 197: 192–93.
  25. Fischer O. Miliare Nekrosen Mit Drusigen Wucherungen der Neurofibrillen, eine Regelmassige Veranderung der Hirnrinde bei Seniler Demenz (Miliary Necrosis with Nodular Proliferation of the Neurofibrils: A Common Change of the Cerebral Cortex in Senile Dementia). Monatsschr f Psychiat Neurol 1907; 22: 361-372.
  26. Leonard JM, des Prez RM. Tuberculous Meningitis. Infect Dis Clin of Nor Amer Dec, 1990; 4: 4: 769–87.
  27. Chantemesse A, Ėtude Sur la Méningite Tuberculeuse de L’adulte: Les Formes Anormales en Particulier. These de Med de Paris. 1884.
  28. Blocq P, Babes V, Marinesco G. Atlas der Pathologischen Histologie des Nervensystems.  Berlin: Hirschwald, 1892.
  29. Vera HD, Rettger LF. Morphological Variation of the Tubercle Bacillus and Certain Recently Isolated Soil Acid Fasts, with Emphasis on Filterability. Journ of Bact June, 1940; 39:6: 659–87.
  30. Babes V, Levaditi C. On the Actinomycotic Shape of the Tuberculosis Bacilli (Sur la Forme Actinomycosique du Bacilli de la Tuberculosis). Arch. of Med. Exp. et D’anat. 1897; 9:6:1041-8.
  31. Blocq P, Marinescu G. Sur les Lesions et la Pathogenie de L’epilepsie Dite Essentielle, Sem Med 1892; 12:445–6.
  32. Giulianz D, Vaca K, Corpuz M. Brain Glia Release Factors with Opposing Actions upon Neuronal Survival, Journ of Neurosci 1993; 13: 29–37.
  33. Curto M, Reali C, Palmieri G, Scintu F, Schivo ML, Sogos V et al., Inhibition of Cytokines Expression in Human Microglia Infected with Virulent and Nonvirulent Mycobacteria. Neurochem Internat 2004; 44: 381–92.
  34. Rock RB, Gekker G, Hu S, Sheng WS, Cheeran M, Lokensgard JR et al. Role of Microglia in Central Nervous System Infections. Clin Microb Rev. 2004; 17: 942–64.
  35. Peterson PK, Gekker G, Hu S, Sheng WS, Anderson WR, Ulevitch RJ et al. CD14 Receptor-Mediated Uptake of Nonopsonized Mycobacterium Tuberculosis by Human Microglia, Infect and Immun. April, 1995; 63:4:1598–602.
  36. Green JA, Elkington PT, Pennington CJ, Roncaroli F, Dholakia S, Moores RC et al. Mycobacterium Tuberculosis Upregulates Microglial Matrix Metalloproteinase-1 and -3 Expression and Secretion via NF-kappaB- and Activator Protein-1-Dependent Monocyte Networks. Journ of Immunol June, 2010;184:11: 6492–503.
  37. Beltan E, Horgen L, Rastogi N. Secretion of Cytokines by Human Macrophages upon Infection by Pathogenic and Nonpathogenic Mycobacteria, Microbio and Pathol. 2000; 28: 313–8.
  38. Fischer O. Die Presbyophrene Demenz, Deren Anatomische Grundlage und Klinische Abgrenzung, Z. Ges. Neurol. Psychiat 1910. 3: 371–471.
  39. Marinesco G, Etude Anatomique et Clinique des Plaques Dites Seniles, 1er semestre Encephale. Paris. 1912; 105–132.
  40. Harbitz F, Grondahl NB, Actinomycosis in Norway: Studies in the Etiology, Modes of Infection, and Treatment, Amer J of Med Sci 1911; 142:386–95.
  41. Woodhead GS. Bacteria and Their Products. London and New York: Walter Scott, Ltd./Charles Scribner’s Sons.1895; 258
  42. Cope VZ. Actinomycosis: The Actinomyces and Some Common Errors about the Actinomyces and Actinomycosis. Postgrad Med. 1952; 28: 572–4.
  43. Bolton CF, Ashenhurst EM, Review Article: Actinomycosis of the Brain. Can Med Assoc Journ April, 1964; 90: 922–8.
  44. Ponfick E, Die Actinomykose des Menschen, Eine Neue Infectionskrankheit auf Vergleichend-Pathologischer und Experimenteller Grundlage Geschildert. Berlin: A. Hirschwald, 1882.
  45. Harz B. Actinomyces Bovis, ein Neuer Schimmel in den Geweben des Rindes: Deutsche Zeitschr. f. their. Med. und Vergl. Path. Zweites Supplementheft. 1870;125
  46. Corper HJ. Complement-Fixation in Tuberculosis. The J of Infect Dis September 1916; 19:3:315–21.
  47. Maurer K, Maurer U. Alzheimer’s disease: The Life of a Physician and the Career of a Disease Chichester, West Sussex: Columbia University Press. 2003.
  48. Bielschowsky M. Die Silberimpragnation der Achsenzylinder. Centralbl 1902; 21:578–84.
  49. Bielschowsky M. Die Silberimpragnation der Neurofibrillen. Centralbl 1903; 22: 997–1006.
  50. Perusini G. Uber Klinisch und Histologish Eigenartige Psychische Erkrankungen des Spateren Lebensalters, in Histologische und Histopathologische Arbeiten, edited by F. Nissl and A. Alzheimer. Jena, Germany: Verlag G. Fischer. 1909; 297–351.
  51. Darzins E. The Bacteriology of Tuberculosis. University of Minnesota Press. 1958; 488:187.
  52. Schneider A, Arau´jo GW, Trajkovic K, Herrmann MM, Merkler D, Mandelkow E et al. Hyperphosphorylation and Aggregation of Tau in Experimental Autoimmune Encephalomyelitis. The J of Biolog Chem Dec, 2004; 279;53: 55833–39.
  53. Harris JE, Fernandez-Vilaseca M, Elkington PTG, Horncastle DE, Graeber MB, Friedland JS et al. IFN Synergizes with IL-1to Up-Regulate MMP-9 Secretion in a Cellular Model of Central Nervous System Tuberculosis, The FASEB J Feb, 2007; 21: 356–65.
  54. Kusebauch U, Ortega C, Ollodart A, Rogers RS, Sherman DR, Moritz RL et al., Mycobacterium Tuberculosis Supports Protein Tyrosine Phosphorylation, Proc of the Nat Acad of Sci June, 2014; 111:25: 9265–70.
  55. Chow K, Ng D, Stokes R, Johnson P. Protein Tyrosine Phosphorylation in Mycobacterium Tuberculosis, FEMS Microbi Letters  December, 1994; 124:2: 203–7.
  56. Shapiro IP, Masliah E, Saitoh T. Altered Protein Tyrosine Phosphorylation in Alzheimer’s disease. J of Neurochem April, 1991; 56:4: 1154–62.
  57. Wang X.-X., Tan M.-S., Yu J.-T., Tan L. Matrix Metalloproteinases and Their Multiple Roles in Alzheimer’s Disease, BioMed Res Internat 2014,
  58. Lubarsch O. Zur Kenntnis der auf die Samenblaschen Amyloidablagerungen, Virch Arch Path Anat 1930; 274:139–145.
  59. Southard EE, Anatomical Findings in Senile Dementia: A Diagnostic Study Bearing Especially on the Group of Cerebral Atrophies. Amer J of Insan April, 1910; 66:4:673–708:701, 706.
  60. Southard EE, Solomon HC. Neurosypilis: Modern Systematic Diagnosis and Treatment—Presented in One Hundred and Thirty-Seven Case Histories 1917; Boston: W. M. Leonard. 496 pp.
  61. Southard EE. Nondementia Nonpraecox: Note on the Advantages to Mental Hygiene of Extirpating a Term in History of Psychiatry, Classic Text No. 72. Los Angeles, London, New Delhi: Sage Publications 2007; 18:4: 483–502.
  62. Southard EE, Jarrett MC. The Kingdom of Evils: Psychiatric Social Work Presented in One Hundred Case Histories Together with a Classification of Social Divisions of Evil. New York: Macmillan 1922; 298–9.
  63. Kraepelin E. Memoirs. Berlin and New York: Springer-Verlag. 1987; 270:136.
  64. Clouston TS, Unsoundness of Mind New York: E. F. Dutton and Co., 1911.
  65. Clouston TS. Illustrations of Phthisical Insanity. J of Ment Sci 1864; 50:220-229: 226.
  66. Clouston TS. Clinical Lectures on Mental Disease. London: J. & A. Churchill, 1883; 210.
  67. Sethi NK, Sethi PK, Torgovnick J, Arsura E. Central Nervous System Tuberculosis Masquerading as Primary Dementia: A Case Report, Neurologia i Neurochirurgia Polska. September-October 2011; 45:5:510–513.
  68. Carpenter EG. Determinate Factors in the Cause of Insanity, Jour of the Amer Med Assoc 1903 Jan 24; 60:4:240–44.
  69. Winslow F. On Obscure Diseases of the Brain and Disorders of the Mind: Their Incipient Symptoms, Pathology, Diagnosis, Treatment, and Prophylaxis. London: John Churchill Publishers. April 1860; 790 pp.
  70. Claisse P and Abrami A. Un Cas de Méningite Tuberculeus Terrninee par Guerison. Bull. et mém. soc. méd. d. hop. de Par.1905; 22:390–403.
  71. Marta M, Pomponi M. Il Ruolo di Perusini Nella Definizione del Morbo di Alzheimer, Kos. 1992; 77: 39–41.
  72. Braun B, Stadlober-Degwerth M, Kluemann H. Alzheimer–Perusini Disease: The One-Hundredth Anniversary of Gaetano Perusini’s Publication. Nervenarzt March 2011; 82:3: 363–66.
  73. Papavoine, LN Propositions Sur Les Tubercules Considérés Spécialement Chez le Enfans. Paris. 1830; 86:231.
  74. Rindfleisch R. Der Miliare Tuberkel. Virchow’s Arch. 1862; 24:571.
  75. Osler W, McCrae T. Modern Medicine: Its Theory and Practice, vol. V: Diseases of the Nervous System, 2nd edition. Philadelphia and New York: Lea & Febiger. 1915; 319.
  76. Guarnieri G. Note Istologiche Sulla Meningite Tubercolare.  Arch. Per le Scien. Med., Torino, 7th ed., 1883 1: 59–70.
  77. Hektoen L. The Vascular Changes of Tuberculous Meningitis, Especially with Tuberculous Endarteritis, J of Exper Med 1896; 1:112-163.
  78. Schwartz P. Amyloidosis—Cause and Manifestation of Senile Deterioration. Springfield, Illinois: Charles C Thomas. 1970; 363.
  79. Schwartz P. Amyloid Degeneration and Tuberculosis in the Aged. Gerontologia 1972; 18:5: 321–62.
  80. Hass GM, Huntington R. Amyloid 111: The Properties of Amyloid Deposits Occurring in Several Species under Diverse Conditions. Arch of Path 1943; 35: 226–41.
  81. Alzheimer A. Uber Eine Eigenartige Erkrankung des Zentralen Nervensystems Mit Bulbaen Symptomen und Schmerzhaften Spastischen Krampfzustanden der Extremitaen, Zeit fur die Gesamte Neurolog und Psychiat. 1916. 33: 45–59.
  82. Maurer K, Volk K, Gerbaldo S. Auguste D and Alzheimer’s disease, The Lancet May 1997; 349: 9064:1546–49.
  83. Jelliffe SE. Proceedings: National Association for the Study and Prevention of Tuberculosis, The Med News January-June, 1905; 86:1150 .
  84. Gerstenbrand F, Jellinger K, Maida E, Pilz A, Sandhofer F, and Weissenbacher G, Symptomatology of the Most Severe Form of Tuberculous Meningitis. J of Neurol 1980; 222:3:191–204.
  85. Kelynack TN. Tuberculosis in Infancy and Childhood. London: Bailliere, Tindall, and Cox. 1908.
  86. Rao VV, Gupta EV, Thomas IM. Chromosome Damage in Untreated Tuberculosis Patients. Tubercle September, 1990; 71:3:169-72.
  87. Wuerthele-Caspe V, Alexander-Jackson E, Gregory M, Smith LW, Diller IC, Mankowski Z. Intracellular Acid-Fast Microorganism: Isolated from Two Cases of Hepatolenticular Degeneration, J of the Amer Med Wom Assoc 1956 11:4:120–9.
  88. Jancovic J, Tolosa E. Parkinson’s Disease and Movement Disorders. Baltimore: Williams & Wilkins 1998; 205-16.
  89. Burn CG, Unidentified Gram-Positive Bacillus Associated with Meningo-Encephalitis, Proc of the Soc for Exper Biol and Med 1934; 31:1095.
  90. Livingston V, A Specific Type of Organism Cultivated from Malignancy: Bacterial and Proposed Classification. Ann of the New York Acad of Sci 1970; 174: 636–54.
  91. Bandelier B, Roepke O, Lehrbuch der Spezifischen Diagnostic und Therapie der Tuberkulose: fur arzte und Studierende Wurzburg: Curt Kabitzsch. 1911.
  92. Bandelier B, Roepke O. A Clinical System of Tuberculosis, translated from the Second German Edition by G. Band and Bertram Hunt, MD. New York: William Wood and Company. 1913.
  93. Nature Editorial, Forthcoming Books. March 13, 1913, Nature 91: 44.
  94. Millar BC, Moore JE, Emerging Issues in Infective Endocarditis, Emerg Infect Dis June, 2004; 10:6: 1110–6.
  95. Liu A, Nicol E, Hu Y, Coates A. Tuberculous Endocarditis, Internat J of Cardiol August, 2013; 167:3: 640–5.
  96. Gordon BL, Ocular Tuberculosis, Its Relation to General Tuberculosis—Ophthalmologic Reviews, edited by Francis Heed Adler. 1944; 541–56.
  97. Sands IJ, Senile and Presenile Psychosis, Neur Bulletin October 1918; 1:10: 377–385.